Healthscope has rallied from $2.02 to $2.30 in the past few weeks, as the market becomes more certain of a positive outcome on the pending takeover offer.
If the takeover fails, shareholder value will be unlocked through the separation of the REIT from the hospital assets.
You're not a member! Trial today
The takeover offer is priced at $2.44 and so far, the due diligence has not uncovered anything to prevent the proposal being formalised. We expect to learn more in the next 4 – 8 weeks.
